| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $211.0M | — | +30.2% |
| Cost of Revenue | $72.3M | — | +42.2% |
| Gross Profit | $138.7M | — | +24.7% |
| R&D Expense | $46.1M | — | +25.3% |
| SG&A Expense | $30.9M | — | -23.7% |
| Operating Income | -$27.5M | — | +31.6% |
| Pre-tax Income | -$24.1M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $145.3M | +16.8% | -37.2% |
| Accounts Receivable | $118.5M | -3.2% | +37.6% |
| Current Assets | $546.7M | -3.7% | -17.1% |
| Total Assets | $1.09B | -2.0% | +22.7% |
| Current Liabilities | $441.5M | +5.0% | +28.4% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.1M | — | +16.5% |
| Capital Expenditures | $108K | — | -50.2% |
| Investing Cash Flow | $42.8M | — | -65.2% |
| Financing Cash Flow | -$49.7M | — | -8313.2% |
| Free Cash Flow | $28.0M | — | +17.1% |
| +30.4% |
| Income Tax | $1.4M | — | +33.3% |
| Net Income | -$26.6M | — | +25.7% |
| EPS (Basic) | -$0.24 | — | +29.4% |
| EPS (Diluted) | -$0.24 | — | +29.4% |
| $507.9M |
| +3.7% |
| +22.5% |
| Stockholders' Equity | $581.7M | -6.7% | +22.6% |